Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#npk-index *,#npk-index *::before,#npk-index *::after{box-sizing:border-box;margin:0;padding:0}\n#npk-index{\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;\n color:#0F2A35;\n background:#F2F8FA;\n line-height:1.8;\n padding:0 0 64px;\n}\n#npk-index .di-header{\n background:linear-gradient(135deg,#114455 0%,#1A5F7A 60%,#236E8C 100%);\n color:#E4F4F9;\n padding:36px 24px 30px;\n text-align:center;\n position:relative;\n overflow:hidden;\n}\n#npk-index .di-header::before{\n content:'';position:absolute;inset:0;\n background:repeating-linear-gradient(45deg,transparent,transparent 18px,rgba(255,255,255,0.03) 18px,rgba(255,255,255,0.03) 19px);\n}\n#npk-index .di-eyebrow{\n font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;\n font-weight:600;opacity:0.65;margin-bottom:10px;position:relative;\n}\n#npk-index .di-title{\n font-family:'Playfair Display',serif;font-size:1.9rem;font-weight:700;\n line-height:1.2;margin-bottom:6px;position:relative;\n}\n#npk-index .di-title em{font-style:italic;font-weight:400;opacity:0.88}\n#npk-index .di-subtitle{font-size:0.85rem;opacity:0.72;font-style:italic;margin-top:8px;position:relative;}\n#npk-index .di-body{max-width:740px;margin:0 auto;padding:0 20px;}\n#npk-index .di-intro{margin:36px 0 28px;font-size:0.97rem;color:#0F2A35;line-height:1.82;}\n#npk-index .di-intro p{margin-bottom:1.1em;}\n#npk-index .di-intro p:last-child{margin-bottom:0;}\n#npk-index .di-section-head{\n font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;\n color:#1A5F7A;margin:36px 0 18px;padding-bottom:6px;\n border-bottom:2px solid #B8D8E3;\n}\n#npk-index .di-card{\n background:#F8FCFD;border:1px solid #B8D8E3;border-left:4px solid #1A5F7A;\n border-radius:10px;padding:18px 20px 16px;margin-bottom:16px;\n box-shadow:0 1px 5px rgba(15,42,53,0.06);\n}\n#npk-index .di-card-link-head{text-decoration:none;color:inherit;display:block;}\n#npk-index .di-card-link-head:hover .di-card-title{text-decoration:underline;text-underline-offset:3px;}\n#npk-index .di-card-num{\n font-size:0.62rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;\n color:#1A5F7A;opacity:0.75;margin-bottom:4px;\n}\n#npk-index .di-card-title{\n font-family:'Playfair Display',serif;font-size:1.05rem;font-weight:700;\n color:#0F2A35;margin-bottom:6px;\n}\n#npk-index .di-card-title .di-arrow{font-size:0.78rem;opacity:0.45;font-style:normal;margin-left:5px;}\n#npk-index .di-card-body{font-size:0.88rem;color:#2A4D5A;line-height:1.72;margin-bottom:12px;}\n#npk-index .di-card-footer{display:flex;justify-content:flex-end;}\n#npk-index .di-card-link{\n display:inline-block;background:#1A5F7A;color:#E4F4F9;text-decoration:none;\n font-family:'Playfair Display',serif;font-size:0.82rem;font-weight:700;\n padding:7px 18px;border-radius:6px;transition:background 0.15s;\n}\n#npk-index .di-card-link:hover{background:#114455;}\n#npk-index .di-beyond{\n background:#F8FCFD;border:1px solid #B8D8E3;border-radius:10px;\n padding:20px 22px;margin:28px 0 0;font-size:0.88rem;color:#2A4D5A;line-height:1.72;\n}\n#npk-index .di-beyond-head{\n font-family:'Playfair Display',serif;font-size:0.95rem;font-weight:700;\n color:#0F2A35;margin-bottom:8px;\n}\n#npk-index .di-feedback{\n margin-top:20px;padding:22px 22px 20px;\n background:#E6F3F7;border:1px solid #B8D8E3;\n border-radius:10px;font-size:0.88rem;color:#2A4D5A;line-height:1.72;\n}\n#npk-index .di-feedback-head{\n font-family:'Playfair Display',serif;font-size:0.95rem;font-weight:700;\n color:#1A5F7A;margin-bottom:8px;\n}\n#npk-index .di-note{\n margin-top:32px;font-size:0.82rem;color:#5A7D8A;\n font-style:italic;text-align:center;line-height:1.6;\n}\n@media(max-width:480px){\n #npk-index .di-title{font-size:1.5rem}\n #npk-index .di-card{padding:14px 16px 13px}\n}\n<\/style>\n\n<div id=\"npk-index\">\n\n <div class=\"di-header\">\n <div class=\"di-eyebrow\">Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics<\/div>\n <div class=\"di-title\">\n Pharmacokinetics<br><em>A Guide to the Numerical Series<\/em>\n <\/div>\n <div class=\"di-subtitle\">Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring<\/div>\n <\/div>\n\n <div class=\"di-body\">\n\n <div class=\"di-intro\">\n <p>Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the right formula, convert units correctly before dividing, and then interpret the number you get in clinical terms rather than simply matching it to an option. A candidate who knows that steady-state concentration equals infusion rate divided by clearance will still drop the mark if they forget to convert millilitres per minute to litres per hour before doing the arithmetic. The formula is the same; the units trap is where the examination happens.<\/p>\n <p>That principle shapes every round in this series. Zero-order and first-order kinetics are not just definitions to memorise \u2014 they generate specific calculation patterns that examiners exploit repeatedly. Half-life arithmetic is not just halving a number \u2014 it underlies washout periods, time to steady state, and the loading-dose rationale for drugs like amiodarone whose half-lives run into weeks. Volume of distribution is not just a pharmacokinetic curiosity \u2014 it explains why haemodialysis fails in digoxin toxicity and why chloroquine overdose is so difficult to treat. Every number in this series has a clinical consequence attached to it.<\/p>\n <p>The seven rounds are sequenced to build from first principles outward. Rounds 01 and 02 establish zero-order versus first-order kinetics and half-life arithmetic. Rounds 03 and 04 move into volume of distribution, loading dose, clearance, and steady-state calculations. Round 05 covers therapeutic index, ED50, and LD50 \u2014 both the formula and the clinical meaning of a narrow safety margin. Round 06 integrates all preceding concepts into clinical scenarios of the kind examiners actually write. Round 07 closes the series on bioavailability, protein binding, and the pharmacokinetic peculiarities of neonates, the elderly, and pregnant patients \u2014 populations where standard doses routinely fail. The Summative Revision file pulls the highest-yield items from all seven rounds into a single consolidated review.<\/p>\n <\/div>\n\n <div class=\"di-section-head\">The Seven Rounds<\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-01.html\">\n <div class=\"di-card-num\">Round 01 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Zero, First & the Order of Elimination <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n The series opener builds on the single most important distinction in kinetics: whether a fixed <em>amount<\/em> or a fixed <em>fraction<\/em> of drug is eliminated per unit time. Five calculations move from three-half-life arithmetic \u2014 the 87.5% answer that trips candidates who add instead of compound \u2014 through zero-order drug remaining after three hours, to plasma concentration at twelve hours using the (\u00bd)<sup>n<\/sup> shortcut, percentage remaining after four half-lives, and total drug eliminated during a zero-order infusion. Each debrief identifies the specific trap built into the wrong options, which in this topic almost always involves applying first-order logic to a zero-order scenario or vice versa.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-01.html\">Open Round 01 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-02.html\">\n <div class=\"di-card-num\">Round 02 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Half-Life & the Arithmetic of Washout <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Half-life arithmetic taken past simple halving into the questions examiners actually set. Time to 95% elimination anchors the round on the 4\u20135 half-life rule. Back-calculating half-life from two plasma concentrations requires identifying the number of halvings in the interval rather than dividing concentrations directly. The MAO inhibitor washout case is the deliberate conceptual trap: phenelzine's plasma half-life is two hours, but its 14-day washout period has nothing to do with pharmacokinetics and everything to do with the time needed for new enzyme synthesis \u2014 the lesson that half-life governs plasma concentration, not always clinical duration. Repeated dosing and time to steady state are tested on the principle that only half-life determines this, not dosing frequency. The round closes on identifying kinetic order from a plasma concentration table \u2014 a question type that appears directly in exams.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-02.html\">Open Round 02 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-03.html\">\n <div class=\"di-card-num\">Round 03 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Volume of Distribution & the Loading Dose <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Vd as a concept, a calculation, and a clinical interpreter. The basic formula \u2014 dose divided by initial plasma concentration \u2014 is established first, then used to interpret where the drug actually resides: plasma (3 L), extracellular fluid (15 L), total body water (42 L), or extensively sequestered in tissues at values no real anatomical compartment can accommodate. The oral loading dose calculation for digoxin introduces the bioavailability correction that the IV formula does not require. A paired comparison of two drugs with Vd of 3.5 L and 700 L respectively applies the haemodialysis corollary directly: dialysis cleans plasma, and a drug distributed across 700 litres leaves almost nothing in plasma to clean. Amiodarone's loading dose rationale tests the calculation for time to steady state without one \u2014 up to 275 days \u2014 and why that is clinically unacceptable for an antiarrhythmic.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-03.html\">Open Round 03 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-04.html\">\n <div class=\"di-card-num\">Round 04 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Clearance & Steady-State Concentration <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Clearance arithmetic, starting with the units trap that accounts for the majority of wrong answers on steady-state questions: infusion rate in mg\/hour divided by clearance in mL\/min requires converting to a common time and volume unit before dividing, not after. Total body clearance from Vd and half-life uses the CL = 0.693 \u00d7 Vd \u00f7 t\u00bd relationship, explaining why half-life lengthens in renal failure (clearance falls) or in obesity (Vd rises). Dose adjustment in renal failure is tested numerically on a drug that is 100% renally cleared, with both dose-reduction and interval-extension strategies shown as valid alternatives. The hepatic extraction ratio case separates flow-dependent from capacity-dependent clearance and identifies which class becomes dangerous in cirrhosis and why. The round closes on the key fact that doubling an infusion rate doubles the new steady-state concentration, but reaching that new steady state still requires 4\u20135 half-lives regardless of where the patient started.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-04.html\">Open Round 04 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-05.html\">\n <div class=\"di-card-num\">Round 05 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Therapeutic Index, ED50 & LD50 <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Therapeutic index from formula to clinical consequence. TI = LD50 \u00f7 ED50 is established with the direction of division made explicit \u2014 inverting it produces a plausible-looking wrong answer of 0.1 rather than 10 \u2014 and the interpretation of a TI of 10 as a wide rather than narrow margin is tested directly against the common misreading. A patient on a drug with TI 1.5 who develops mild renal impairment shows what a 30% reduction in clearance means when there is almost no safety margin to absorb it. Potency and efficacy are separated on ED50 and maximum effect respectively, with the explicit point that the more potent drug is not always the better or safer clinical choice. The Certain Safety Factor \u2014 TD1 \u00f7 ED99 \u2014 introduces the population-overlap question that classic median-based TI cannot answer. The round closes on a two-drug comparison where the less potent drug is clearly the correct clinical choice because its safety margin is nearly seven times wider.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-05.html\">Open Round 05 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-06.html\">\n <div class=\"di-card-num\">Round 06 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Mixed Clinical Numericals <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n All five preceding concept areas embedded inside clinical scenarios of the kind examination writers actually construct. A digoxin toxicity case requires calculating total body burden from plasma concentration and Vd, then using that number to argue against haemodialysis \u2014 with the calculation showing that under 1% of total body digoxin resides in plasma at any time. A theophylline maintenance dose calculation repeats the mL\/min to L\/hr unit trap from Round 04 in a different clinical wrapper. A phenytoin case tests Michaelis-Menten kinetics numerically: a 33% dose increase produces a 200% rise in plasma concentration, and the debrief explains why the saturation of hepatic hydroxylation enzymes makes this non-linear response inevitable near therapeutic levels. Thiopentone's rapid offset despite an 11-hour half-life demonstrates two-compartment redistribution as the mechanism behind induction agent pharmacology. The round closes on bioavailability calculated from AUC data across two different routes and two different doses \u2014 requiring dose normalisation before the ratio can be taken.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-06.html\">Open Round 06 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-07.html\">\n <div class=\"di-card-num\">Round 07 \u00b7 Pharmacokinetics Numerical Series \u00b7 Series Finale<\/div>\n <div class=\"di-card-title\">Bioavailability, Protein Binding & Special Populations <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n The series closes on the pharmacokinetic consequences of route, binding, and population. GTN swallowed versus placed sublingually is a portal vein anatomy question before it is a pharmacokinetics question: swallowed GTN reaches the liver first and loses over 99% to first-pass metabolism, while sublingual GTN drains directly into the superior vena cava. Warfarin displaced from albumin by phenylbutazone shows how a shift from 99% to 98% bound doubles the free fraction and doubles pharmacological effect on the same total dose. Neonatal pharmacokinetics covers immature GFR, CYP450 immaturity, glucuronidation deficiency, and the higher total body water that widens Vd for water-soluble drugs. The elderly creatinine trap shows how sarcopenia-related reduced creatinine production makes serum creatinine appear normal despite severe renal impairment \u2014 with Cockcroft-Gault calculation made mandatory. The series closes on pregnancy: falling albumin, expanding plasma volume, and the competing effects of each on free drug fraction and apparent Vd.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-07.html\">Open Round 07 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-beyond\">\n <div class=\"di-beyond-head\">Topics not covered in this series<\/div>\n This series covers the pharmacokinetic numericals most commonly examined at NEET-PG, INI-CET, and UPSC CMS level, but is not exhaustive. Areas outside these seven rounds include: pharmacodynamic calculations (receptor occupancy, Bmax, Kd from binding curves), drug-drug interaction kinetics beyond the extraction ratio and protein-displacement cases covered here, population pharmacokinetics and variability modelling, organ-specific clearance calculations for hepatic blood flow measurement (e.g. indocyanine green clearance), and the full breadth of paediatric dose scaling methods beyond the neonatal kinetics covered in Round 07. Each warrants separate treatment and will be addressed in future series as question-bank analysis confirms their examination frequency.\n <\/div>\n\n \n <div class=\"di-feedback\">\n <div class=\"di-feedback-head\">A note for examinees<\/div>\n Pharmacokinetics MCQs at NEET-PG and INI-CET reward the candidate who sets up the calculation correctly before touching a number. The formula matters; the units matter at least as much; and the interpretation of the result matters most in the questions that are actually hard. A steady-state concentration of 33.33 mg\/L is wrong if you divided mg\/hour by mL\/min without converting. A loading dose calculation is wrong if you forget to divide by bioavailability for the oral route. A haemodialysis decision is wrong if you apply it to a drug with a Vd of 500 litres without asking how much of the total drug burden is actually in plasma to be filtered. If any case in this series is factually incorrect, pitched at the wrong level, or missing a nuance that matters in examination practice, the contact page is open. Corrections sharpen every subsequent round.\n <\/div>\n\n \n <div class=\"di-feedback\" style=\"margin-top:16px;background:#F2F8FA;border-color:#B8D8E3;\">\n <div class=\"di-feedback-head\">Summative Revision<\/div>\n A companion summative revision file covers all seven topics in condensed form \u2014 formula reference table, unit conversion anchors, kinetic order decision tree, compartment volume benchmarks, NTI drug list with clinical consequences, and population-specific adjustment rules \u2014 designed for rapid pre-exam consolidation rather than first-time learning. <a href=\"mr-npk-sr.html\" style=\"color:#1A5F7A;font-weight:600;\">Open Summative Revision \u2192<\/a>\n <\/div>\n\n <div class=\"di-note\">\n Morning Rounds \u00b7 atsixty.com \u00b7 Numerical Series \u00b7 Pharmacokinetics \u00b7 Seven rounds \u00b7 35 questions \u00b7 +4 \/ \u22121 scoring \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS\n <\/div>\n\n <\/div>\n<\/div>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"[\"title\",\"meta\",\"content\",\"tags\",\"comments\"]","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,79],"tags":[83],"class_list":["post-37335","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-pharmacology","tag-neet-pg"],"yoast_head":"\n<title>Pharmacokinetics - An Index to the Numerical Series - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacokinetics - An Index to the Numerical Series - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… \" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-23T04:29:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-23T04:41:58+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pharmacokinetics – An Index to the Numerical Series\",\"datePublished\":\"2026-08-23T04:29:18+00:00\",\"dateModified\":\"2026-08-23T04:41:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"},\"wordCount\":1691,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"Pharmacology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\",\"name\":\"Pharmacokinetics - An Index to the Numerical Series - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-08-23T04:29:18+00:00\",\"dateModified\":\"2026-08-23T04:41:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacokinetics – An Index to the Numerical Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n","yoast_head_json":{"title":"Pharmacokinetics - An Index to the Numerical Series - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacokinetics - An Index to the Numerical Series - atsixty","og_description":"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… ","og_url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","og_site_name":"atsixty","article_published_time":"2026-08-23T04:29:18+00:00","article_modified_time":"2026-08-23T04:41:58+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pharmacokinetics – An Index to the Numerical Series","datePublished":"2026-08-23T04:29:18+00:00","dateModified":"2026-08-23T04:41:58+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"},"wordCount":1691,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["NEET-PG"],"articleSection":["Morning Rounds","Pharmacology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","name":"Pharmacokinetics - An Index to the Numerical Series - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-08-23T04:29:18+00:00","dateModified":"2026-08-23T04:41:58+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacokinetics – An Index to the Numerical Series"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37335"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335\/revisions"}],"predecessor-version":[{"id":37336,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335\/revisions\/37336"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":37335,"date":"2026-08-23T09:59:18","date_gmt":"2026-08-23T04:29:18","guid":{"rendered":"https:\/\/atsixty.com\/?p=37335"},"modified":"2026-08-23T10:11:58","modified_gmt":"2026-08-23T04:41:58","slug":"pharmacokinetics-an-index-to-the-numerical-series","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","title":{"rendered":"Pharmacokinetics – An Index to the Numerical Series"},"content":{"rendered":"\n\n\n\n\n\nMorning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#npk-index *,#npk-index *::before,#npk-index *::after{box-sizing:border-box;margin:0;padding:0}\n#npk-index{\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;\n color:#0F2A35;\n background:#F2F8FA;\n line-height:1.8;\n padding:0 0 64px;\n}\n#npk-index .di-header{\n background:linear-gradient(135deg,#114455 0%,#1A5F7A 60%,#236E8C 100%);\n color:#E4F4F9;\n padding:36px 24px 30px;\n text-align:center;\n position:relative;\n overflow:hidden;\n}\n#npk-index .di-header::before{\n content:'';position:absolute;inset:0;\n background:repeating-linear-gradient(45deg,transparent,transparent 18px,rgba(255,255,255,0.03) 18px,rgba(255,255,255,0.03) 19px);\n}\n#npk-index .di-eyebrow{\n font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;\n font-weight:600;opacity:0.65;margin-bottom:10px;position:relative;\n}\n#npk-index .di-title{\n font-family:'Playfair Display',serif;font-size:1.9rem;font-weight:700;\n line-height:1.2;margin-bottom:6px;position:relative;\n}\n#npk-index .di-title em{font-style:italic;font-weight:400;opacity:0.88}\n#npk-index .di-subtitle{font-size:0.85rem;opacity:0.72;font-style:italic;margin-top:8px;position:relative;}\n#npk-index .di-body{max-width:740px;margin:0 auto;padding:0 20px;}\n#npk-index .di-intro{margin:36px 0 28px;font-size:0.97rem;color:#0F2A35;line-height:1.82;}\n#npk-index .di-intro p{margin-bottom:1.1em;}\n#npk-index .di-intro p:last-child{margin-bottom:0;}\n#npk-index .di-section-head{\n font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;\n color:#1A5F7A;margin:36px 0 18px;padding-bottom:6px;\n border-bottom:2px solid #B8D8E3;\n}\n#npk-index .di-card{\n background:#F8FCFD;border:1px solid #B8D8E3;border-left:4px solid #1A5F7A;\n border-radius:10px;padding:18px 20px 16px;margin-bottom:16px;\n box-shadow:0 1px 5px rgba(15,42,53,0.06);\n}\n#npk-index .di-card-link-head{text-decoration:none;color:inherit;display:block;}\n#npk-index .di-card-link-head:hover .di-card-title{text-decoration:underline;text-underline-offset:3px;}\n#npk-index .di-card-num{\n font-size:0.62rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;\n color:#1A5F7A;opacity:0.75;margin-bottom:4px;\n}\n#npk-index .di-card-title{\n font-family:'Playfair Display',serif;font-size:1.05rem;font-weight:700;\n color:#0F2A35;margin-bottom:6px;\n}\n#npk-index .di-card-title .di-arrow{font-size:0.78rem;opacity:0.45;font-style:normal;margin-left:5px;}\n#npk-index .di-card-body{font-size:0.88rem;color:#2A4D5A;line-height:1.72;margin-bottom:12px;}\n#npk-index .di-card-footer{display:flex;justify-content:flex-end;}\n#npk-index .di-card-link{\n display:inline-block;background:#1A5F7A;color:#E4F4F9;text-decoration:none;\n font-family:'Playfair Display',serif;font-size:0.82rem;font-weight:700;\n padding:7px 18px;border-radius:6px;transition:background 0.15s;\n}\n#npk-index .di-card-link:hover{background:#114455;}\n#npk-index .di-beyond{\n background:#F8FCFD;border:1px solid #B8D8E3;border-radius:10px;\n padding:20px 22px;margin:28px 0 0;font-size:0.88rem;color:#2A4D5A;line-height:1.72;\n}\n#npk-index .di-beyond-head{\n font-family:'Playfair Display',serif;font-size:0.95rem;font-weight:700;\n color:#0F2A35;margin-bottom:8px;\n}\n#npk-index .di-feedback{\n margin-top:20px;padding:22px 22px 20px;\n background:#E6F3F7;border:1px solid #B8D8E3;\n border-radius:10px;font-size:0.88rem;color:#2A4D5A;line-height:1.72;\n}\n#npk-index .di-feedback-head{\n font-family:'Playfair Display',serif;font-size:0.95rem;font-weight:700;\n color:#1A5F7A;margin-bottom:8px;\n}\n#npk-index .di-note{\n margin-top:32px;font-size:0.82rem;color:#5A7D8A;\n font-style:italic;text-align:center;line-height:1.6;\n}\n@media(max-width:480px){\n #npk-index .di-title{font-size:1.5rem}\n #npk-index .di-card{padding:14px 16px 13px}\n}\n<\/style>\n\n<div id=\"npk-index\">\n\n <div class=\"di-header\">\n <div class=\"di-eyebrow\">Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics<\/div>\n <div class=\"di-title\">\n Pharmacokinetics<br><em>A Guide to the Numerical Series<\/em>\n <\/div>\n <div class=\"di-subtitle\">Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring<\/div>\n <\/div>\n\n <div class=\"di-body\">\n\n <div class=\"di-intro\">\n <p>Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the right formula, convert units correctly before dividing, and then interpret the number you get in clinical terms rather than simply matching it to an option. A candidate who knows that steady-state concentration equals infusion rate divided by clearance will still drop the mark if they forget to convert millilitres per minute to litres per hour before doing the arithmetic. The formula is the same; the units trap is where the examination happens.<\/p>\n <p>That principle shapes every round in this series. Zero-order and first-order kinetics are not just definitions to memorise \u2014 they generate specific calculation patterns that examiners exploit repeatedly. Half-life arithmetic is not just halving a number \u2014 it underlies washout periods, time to steady state, and the loading-dose rationale for drugs like amiodarone whose half-lives run into weeks. Volume of distribution is not just a pharmacokinetic curiosity \u2014 it explains why haemodialysis fails in digoxin toxicity and why chloroquine overdose is so difficult to treat. Every number in this series has a clinical consequence attached to it.<\/p>\n <p>The seven rounds are sequenced to build from first principles outward. Rounds 01 and 02 establish zero-order versus first-order kinetics and half-life arithmetic. Rounds 03 and 04 move into volume of distribution, loading dose, clearance, and steady-state calculations. Round 05 covers therapeutic index, ED50, and LD50 \u2014 both the formula and the clinical meaning of a narrow safety margin. Round 06 integrates all preceding concepts into clinical scenarios of the kind examiners actually write. Round 07 closes the series on bioavailability, protein binding, and the pharmacokinetic peculiarities of neonates, the elderly, and pregnant patients \u2014 populations where standard doses routinely fail. The Summative Revision file pulls the highest-yield items from all seven rounds into a single consolidated review.<\/p>\n <\/div>\n\n <div class=\"di-section-head\">The Seven Rounds<\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-01.html\">\n <div class=\"di-card-num\">Round 01 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Zero, First & the Order of Elimination <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n The series opener builds on the single most important distinction in kinetics: whether a fixed <em>amount<\/em> or a fixed <em>fraction<\/em> of drug is eliminated per unit time. Five calculations move from three-half-life arithmetic \u2014 the 87.5% answer that trips candidates who add instead of compound \u2014 through zero-order drug remaining after three hours, to plasma concentration at twelve hours using the (\u00bd)<sup>n<\/sup> shortcut, percentage remaining after four half-lives, and total drug eliminated during a zero-order infusion. Each debrief identifies the specific trap built into the wrong options, which in this topic almost always involves applying first-order logic to a zero-order scenario or vice versa.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-01.html\">Open Round 01 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-02.html\">\n <div class=\"di-card-num\">Round 02 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Half-Life & the Arithmetic of Washout <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Half-life arithmetic taken past simple halving into the questions examiners actually set. Time to 95% elimination anchors the round on the 4\u20135 half-life rule. Back-calculating half-life from two plasma concentrations requires identifying the number of halvings in the interval rather than dividing concentrations directly. The MAO inhibitor washout case is the deliberate conceptual trap: phenelzine's plasma half-life is two hours, but its 14-day washout period has nothing to do with pharmacokinetics and everything to do with the time needed for new enzyme synthesis \u2014 the lesson that half-life governs plasma concentration, not always clinical duration. Repeated dosing and time to steady state are tested on the principle that only half-life determines this, not dosing frequency. The round closes on identifying kinetic order from a plasma concentration table \u2014 a question type that appears directly in exams.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-02.html\">Open Round 02 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-03.html\">\n <div class=\"di-card-num\">Round 03 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Volume of Distribution & the Loading Dose <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Vd as a concept, a calculation, and a clinical interpreter. The basic formula \u2014 dose divided by initial plasma concentration \u2014 is established first, then used to interpret where the drug actually resides: plasma (3 L), extracellular fluid (15 L), total body water (42 L), or extensively sequestered in tissues at values no real anatomical compartment can accommodate. The oral loading dose calculation for digoxin introduces the bioavailability correction that the IV formula does not require. A paired comparison of two drugs with Vd of 3.5 L and 700 L respectively applies the haemodialysis corollary directly: dialysis cleans plasma, and a drug distributed across 700 litres leaves almost nothing in plasma to clean. Amiodarone's loading dose rationale tests the calculation for time to steady state without one \u2014 up to 275 days \u2014 and why that is clinically unacceptable for an antiarrhythmic.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-03.html\">Open Round 03 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-04.html\">\n <div class=\"di-card-num\">Round 04 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Clearance & Steady-State Concentration <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Clearance arithmetic, starting with the units trap that accounts for the majority of wrong answers on steady-state questions: infusion rate in mg\/hour divided by clearance in mL\/min requires converting to a common time and volume unit before dividing, not after. Total body clearance from Vd and half-life uses the CL = 0.693 \u00d7 Vd \u00f7 t\u00bd relationship, explaining why half-life lengthens in renal failure (clearance falls) or in obesity (Vd rises). Dose adjustment in renal failure is tested numerically on a drug that is 100% renally cleared, with both dose-reduction and interval-extension strategies shown as valid alternatives. The hepatic extraction ratio case separates flow-dependent from capacity-dependent clearance and identifies which class becomes dangerous in cirrhosis and why. The round closes on the key fact that doubling an infusion rate doubles the new steady-state concentration, but reaching that new steady state still requires 4\u20135 half-lives regardless of where the patient started.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-04.html\">Open Round 04 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-05.html\">\n <div class=\"di-card-num\">Round 05 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Therapeutic Index, ED50 & LD50 <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n Therapeutic index from formula to clinical consequence. TI = LD50 \u00f7 ED50 is established with the direction of division made explicit \u2014 inverting it produces a plausible-looking wrong answer of 0.1 rather than 10 \u2014 and the interpretation of a TI of 10 as a wide rather than narrow margin is tested directly against the common misreading. A patient on a drug with TI 1.5 who develops mild renal impairment shows what a 30% reduction in clearance means when there is almost no safety margin to absorb it. Potency and efficacy are separated on ED50 and maximum effect respectively, with the explicit point that the more potent drug is not always the better or safer clinical choice. The Certain Safety Factor \u2014 TD1 \u00f7 ED99 \u2014 introduces the population-overlap question that classic median-based TI cannot answer. The round closes on a two-drug comparison where the less potent drug is clearly the correct clinical choice because its safety margin is nearly seven times wider.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-05.html\">Open Round 05 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-06.html\">\n <div class=\"di-card-num\">Round 06 \u00b7 Pharmacokinetics Numerical Series<\/div>\n <div class=\"di-card-title\">Mixed Clinical Numericals <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n All five preceding concept areas embedded inside clinical scenarios of the kind examination writers actually construct. A digoxin toxicity case requires calculating total body burden from plasma concentration and Vd, then using that number to argue against haemodialysis \u2014 with the calculation showing that under 1% of total body digoxin resides in plasma at any time. A theophylline maintenance dose calculation repeats the mL\/min to L\/hr unit trap from Round 04 in a different clinical wrapper. A phenytoin case tests Michaelis-Menten kinetics numerically: a 33% dose increase produces a 200% rise in plasma concentration, and the debrief explains why the saturation of hepatic hydroxylation enzymes makes this non-linear response inevitable near therapeutic levels. Thiopentone's rapid offset despite an 11-hour half-life demonstrates two-compartment redistribution as the mechanism behind induction agent pharmacology. The round closes on bioavailability calculated from AUC data across two different routes and two different doses \u2014 requiring dose normalisation before the ratio can be taken.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-06.html\">Open Round 06 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-card\">\n <a class=\"di-card-link-head\" href=\"mr-npk-07.html\">\n <div class=\"di-card-num\">Round 07 \u00b7 Pharmacokinetics Numerical Series \u00b7 Series Finale<\/div>\n <div class=\"di-card-title\">Bioavailability, Protein Binding & Special Populations <span class=\"di-arrow\">\u2197<\/span><\/div>\n <\/a>\n <div class=\"di-card-body\">\n The series closes on the pharmacokinetic consequences of route, binding, and population. GTN swallowed versus placed sublingually is a portal vein anatomy question before it is a pharmacokinetics question: swallowed GTN reaches the liver first and loses over 99% to first-pass metabolism, while sublingual GTN drains directly into the superior vena cava. Warfarin displaced from albumin by phenylbutazone shows how a shift from 99% to 98% bound doubles the free fraction and doubles pharmacological effect on the same total dose. Neonatal pharmacokinetics covers immature GFR, CYP450 immaturity, glucuronidation deficiency, and the higher total body water that widens Vd for water-soluble drugs. The elderly creatinine trap shows how sarcopenia-related reduced creatinine production makes serum creatinine appear normal despite severe renal impairment \u2014 with Cockcroft-Gault calculation made mandatory. The series closes on pregnancy: falling albumin, expanding plasma volume, and the competing effects of each on free drug fraction and apparent Vd.\n <\/div>\n <div class=\"di-card-footer\">\n <a class=\"di-card-link\" href=\"mr-npk-07.html\">Open Round 07 \u2192<\/a>\n <\/div>\n <\/div>\n\n \n <div class=\"di-beyond\">\n <div class=\"di-beyond-head\">Topics not covered in this series<\/div>\n This series covers the pharmacokinetic numericals most commonly examined at NEET-PG, INI-CET, and UPSC CMS level, but is not exhaustive. Areas outside these seven rounds include: pharmacodynamic calculations (receptor occupancy, Bmax, Kd from binding curves), drug-drug interaction kinetics beyond the extraction ratio and protein-displacement cases covered here, population pharmacokinetics and variability modelling, organ-specific clearance calculations for hepatic blood flow measurement (e.g. indocyanine green clearance), and the full breadth of paediatric dose scaling methods beyond the neonatal kinetics covered in Round 07. Each warrants separate treatment and will be addressed in future series as question-bank analysis confirms their examination frequency.\n <\/div>\n\n \n <div class=\"di-feedback\">\n <div class=\"di-feedback-head\">A note for examinees<\/div>\n Pharmacokinetics MCQs at NEET-PG and INI-CET reward the candidate who sets up the calculation correctly before touching a number. The formula matters; the units matter at least as much; and the interpretation of the result matters most in the questions that are actually hard. A steady-state concentration of 33.33 mg\/L is wrong if you divided mg\/hour by mL\/min without converting. A loading dose calculation is wrong if you forget to divide by bioavailability for the oral route. A haemodialysis decision is wrong if you apply it to a drug with a Vd of 500 litres without asking how much of the total drug burden is actually in plasma to be filtered. If any case in this series is factually incorrect, pitched at the wrong level, or missing a nuance that matters in examination practice, the contact page is open. Corrections sharpen every subsequent round.\n <\/div>\n\n \n <div class=\"di-feedback\" style=\"margin-top:16px;background:#F2F8FA;border-color:#B8D8E3;\">\n <div class=\"di-feedback-head\">Summative Revision<\/div>\n A companion summative revision file covers all seven topics in condensed form \u2014 formula reference table, unit conversion anchors, kinetic order decision tree, compartment volume benchmarks, NTI drug list with clinical consequences, and population-specific adjustment rules \u2014 designed for rapid pre-exam consolidation rather than first-time learning. <a href=\"mr-npk-sr.html\" style=\"color:#1A5F7A;font-weight:600;\">Open Summative Revision \u2192<\/a>\n <\/div>\n\n <div class=\"di-note\">\n Morning Rounds \u00b7 atsixty.com \u00b7 Numerical Series \u00b7 Pharmacokinetics \u00b7 Seven rounds \u00b7 35 questions \u00b7 +4 \/ \u22121 scoring \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS\n <\/div>\n\n <\/div>\n<\/div>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"[\"title\",\"meta\",\"content\",\"tags\",\"comments\"]","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,79],"tags":[83],"class_list":["post-37335","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-pharmacology","tag-neet-pg"],"yoast_head":"\n<title>Pharmacokinetics - An Index to the Numerical Series - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacokinetics - An Index to the Numerical Series - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… \" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-23T04:29:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-23T04:41:58+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pharmacokinetics – An Index to the Numerical Series\",\"datePublished\":\"2026-08-23T04:29:18+00:00\",\"dateModified\":\"2026-08-23T04:41:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"},\"wordCount\":1691,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"Pharmacology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\",\"name\":\"Pharmacokinetics - An Index to the Numerical Series - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-08-23T04:29:18+00:00\",\"dateModified\":\"2026-08-23T04:41:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-an-index-to-the-numerical-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacokinetics – An Index to the Numerical Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n","yoast_head_json":{"title":"Pharmacokinetics - An Index to the Numerical Series - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacokinetics - An Index to the Numerical Series - atsixty","og_description":"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Series Index Morning Rounds \u00b7 Numerical Series \u00b7 Pharmacokinetics PharmacokineticsA Guide to the Numerical Series Seven calculation-focused rounds \u00b7 35 questions \u00b7 NEET-PG \/ INI-CET \/ UPSC CMS \u00b7 +4 \/ \u22121 scoring Pharmacokinetics MCQs in Indian PG entrance examinations reward a particular discipline: the ability to set up the… ","og_url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","og_site_name":"atsixty","article_published_time":"2026-08-23T04:29:18+00:00","article_modified_time":"2026-08-23T04:41:58+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pharmacokinetics – An Index to the Numerical Series","datePublished":"2026-08-23T04:29:18+00:00","dateModified":"2026-08-23T04:41:58+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"},"wordCount":1691,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["NEET-PG"],"articleSection":["Morning Rounds","Pharmacology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/","name":"Pharmacokinetics - An Index to the Numerical Series - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-08-23T04:29:18+00:00","dateModified":"2026-08-23T04:41:58+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-an-index-to-the-numerical-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacokinetics – An Index to the Numerical Series"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37335"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335\/revisions"}],"predecessor-version":[{"id":37336,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37335\/revisions\/37336"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}